ReachMD

Episodes 1-15 of 169

• • 

    

    Paul P. Doghramji, MD, FAAFP

    Peer

  • 

    

    Edward S. Kim, MD

    Peer

  0

  

  RestartResume

  Creating Targeted Treatment Pathways Driven by Genomic Makeup & Cancer Type

• • 

    

    Edward S. Kim, MD

    Peer

  0

  

  RestartResume

  Understanding the Importance of RET Mutation as a Primary Oncogenic Driver

• • 

    

    Linda Bernstein, Pharm.D.

    Peer

  0

  

  RestartResume

  FDA’s Pursuit in Progressing Gene Therapy While Maintaining Safety

• • 

    

    Paul Doghramji, MD

    Peer

  • 

    

    Gregory Sawicki, MD, MPH

    Peer

  2

  

  RestartResume

  An In-Depth Look at the Evolution of Cystic Fibrosis Treatments

• • 

    

    Mario R. Nacinovich, Jr., MSc

    Peer

  • 

    

    Paul Orchard, MD

    Peer

  5

  

  RestartResume

  Keys to Avoiding an Adrenoleukodystrophy Misdiagnosis

• • 

    

    Mimi Secor, DNP, FNP-BC, FAANP

    Peer

  • 

    

    James B, Potash, MD, MPH

    Peer

  3

  

  RestartResume

  Genetic Testing for Psychiatric Disorders: Is It Ready for Primetime?

• • 

    

    Matt Birnholz, MD

    Peer

  • 

    

    Nadine Tung, MD

    Peer

  1

  

  RestartResume

  What to Look for When Testing for Hereditary Breast Cancer

• • 

    

    Jenn Simmons, MD

    Peer

  • 

    

    Susan Domchek, MD

    Peer

  4

  

  RestartResume

  Family Matters: The Link Between Family History & BRCA Mutations

• • 

    

    Jenn Simmons, MD

    Peer

  • 

    

    Susan Domchek, MD

    Peer

  0

  

  RestartResume

  Genetic Testing for Hereditary Breast & Ovarian Cancers: What the Guidelines Say

• • 

    

    John F. Brandsema, MD

    Peer

  3

  

  RestartResume

  Increasing Awareness and Access to Spinal Muscular Atrophy Therapy
• 1

  

  RestartResume

  Smart Phones, Genomics and AI: Health Care's Next Frontier in Personalized Me...

• • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Jean Bennett, MD, PhD

    Peer

  • 

    

    Albert Maguire, MD

    Peer

  22

  

  RestartResume

  FDA-Approved Gene Therapy Reverses Blindness in Children & Adults

• • 

    

    Paul Rokuskie

    Peer

  20

  

  RestartResume

  Autism Spectrum Disorder Risk Factors: Environmental and Genetic Components

• • 

    

    Shira Johnson, MD

    Peer

  • 

    

    Robert Vonderheide, MD

    Peer

  23

  

  RestartResume

  CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer

• • 

    

    David Weisman, MD

    Peer

  • 

    

    John Khoury, MD

    Peer

  14

  

  RestartResume

  Expert Debate: The Ethics of Consumer Genetic Testing

• 1
• 2
• 3
• …
• 11
• 12
• Next